cas 1146080-39-8|| where to buy 3-(pyrimidin-2-yl)-1H-indole

Nom du produit:3-(pyrimidin-2-yl)-1H-indole

IUPAC Name:3-(pyrimidin-2-yl)-1H-indole

Unité d'emballage	Stock disponible	Prix($)	Quantité
CM148909-1g	in stock	ƤſƼ

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 1146080-39-8 regularly via the above email.

Notes supplémentaires

Verification code*

refresh

: N° CAS:1146080-39-8; Formule moléculaire:C12H9N3; Point de fusion:-; Code SMILES:C1(C2=NC=CC=N2)=CNC3=C1C=CC=C3; Densité:

: Numéro de catalogue:CM148909; Poids moléculaire:195.23; Point d'ébullition:; N° Mdl:MFCD11915920; Stockage:

: Indoles; Indole is a compound of pyrrole and benzene in parallel, also known as benzopyrrole. There are two combinations of pyrrole and benzene, called indole and isoindole, respectively. Many derivatives of indole have physiological and pharmacological activities, and can synthesize vasodilators, antihistamines, antipyretic analgesics, etc. in medicine, so indole is also a very important heterocyclic compound.; indole company; As a indole company,we sincerely welcome the new and old friends from home and abroad to synergize with our company and share the benefits and opportunities.

: Pyrimidines; Pyrimidine, also known as 1,3-diazobenzene, is a heterocyclic compound with the chemical formula C4H4N2. Pyrimidine is formed by substituting 2 nitrogen atoms for 2 carbons in the meta-position of benzene. It is a diazine and retains its aromaticity. Derivatives of pyrimidine widely exist in organic macromolecular nucleic acids, and many drugs also contain pyrimidine rings. In nucleic acids, three nucleobases are pyrimidine derivatives: cytosine, thymine and uracil. There are a variety of pyrimidine-containing drugs on the market, most of which are kinase inhibitors.